Immune / Resilience Protocol

Goal

Counter Immunosenescence and bolster immune function (infection defense, surveillance, lower chronic inflammation).

Provenance & framing

Research/educational only. Thymosin α1 is approved in 35+ countries (not US); the rest are research-use.

Why it synergises (three layers)

• Peptides: Thymosin Alpha-1 (dendritic/T-cell, the lead immune modulator — 11,000+ patients), Thymulin (zinc-dependent thymic hormone — raise via adequate zinc), Tuftsin (phagocytosis + macrophage M1→M2), KPV (anti-inflammatory), BPC-157 (gut immunity).
• Behaviors: Sleep Hygiene (immune repair), Sauna/Cold Plunge (hormesis), Fasting (autophagy/immune renewal).

Timing & intake

• Thymosin α1 ~2.5 mg 2×/wk (travel/illness-season prophylaxis); ensure zinc sufficiency for thymulin; cycle.

Cautions

• [warning] Immune modulation (not blanket stimulation); caution with autoimmune conditions; thymulin requires zinc.

When to consider

• CD4:CD8 ratio <1 (immunosenescence marker, common past 60), recurrent infections, or post-viral immune dysregulation.

Evidence backing

• Longevity Top-5 (thymosin α1); Bakri (thymulin/thymus biology).

Monitoring

• CD4:CD8, lymphocyte:monocyte ratio, infection frequency.